Filter
441
Filtered Results: 441
Text search:
pharmacokinetics
Featured
Recommendations
56
New Publications
89
Language
Document type
No document type
230
Guidelines
102
Studies & Reports
66
Manuals
20
Training Material
8
Fact sheets
7
Strategic & Response Plan
6
Situation Updates
1
Online Courses
1
Countries / Regions
India
24
Global
13
Ethiopia
12
Kenya
8
Latin America and the Carribbean
8
South Africa
7
Russia
7
Africa
6
Western and Central Europe
6
Sierra Leone
5
Zimbabwe
5
Germany
5
Bangladesh
5
Uganda
5
Zambia
5
Ghana
4
Eastern Europe
4
Brazil
4
Namibia
4
Ukraine
3
Rwanda
3
Nigeria
3
Tanzania
3
South–East Asia Region
3
East and Southern Africa
3
Argentina
3
Liberia
3
Thailand
2
Cameroon
2
Cambodia
2
West and Central Africa
2
Paraguay
2
Eswatini/ Swaziland
2
Nepal
1
Lesotho
1
Australia
1
Syria
1
Burkina Faso
1
Philippines
1
Mozambique
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
North America
1
Denmark
1
Sri Lanka
1
Sudan
1
Angola
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
121
Clinical Guidelines
101
Public Health
19
Women & Child Health
17
Capacity Building
4
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
TB
68
HIV
58
AMR
37
Mental Health
25
Pharmacy
25
NTDs
23
COVID-19
17
Malaria
14
Ebola & Marburg
12
NCDs
10
Refugee
6
Planetary Health
6
Rapid Response
5
Caregiver
5
Disability
3
Polio
2
Global Health Education
2
Natural Hazards
1
Conflict
1
The Transatlantic Task Force on Antimicrobial Resistance (TATFAR) fosters cooperation between the European Union (EU) andthe United States (US) on the issue of antimicrobial resistance. The first TATFAR recommendation refers to appropriate use of antimicrobials in human medicine through hospital Ant...
Las recomendaciones contenidas en este módulo son un componente de las directrices unificadas de la OMS sobre la tuberculosis (TB) y están destinadas principalmente para el uso de los programas nacionales de control de la tuberculosis, los organismos de salud pública y otros interesados clave que...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Lancet Respir Med 2020Published OnlineMarch 20, 2020https://doi.org/10.1016/S2213-2600(20)30121-1
Preferred product characteristics and clinical development considerations
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
Рекомендации, представленные в документе, в значительной степени
базируются на материалах по диагностике, профилактике и лечению COVID19, опубликованных специалист...
Addressing comorbidity between mental disorders and major noncommunicable diseases (Russian Version)
N Engl J Med 2019;380:2429-39.DOI: 10.1056/NEJMoa1901113
Journal of The Association of Physicians of India, Vol. 63 November 2015,, pp.77-96
WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
